⌘K

Login Start Free

Home/Filings/4/0001209191-17-052901

4//SEC Filing

Graney Thomas 4

Accession 0001209191-17-052901

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 8:28 AM ET

Size

4.8 KB

Accession

0001209191-17-052901

Insider Transaction Report

Form 4

Period: 2017-09-13

VERTEX PHARMACEUTICALS INC / MAVRTX

Chief Financial Officer

Transactions

Award
Common Stock
2017-09-13+9,566→ 9,566 total

Footnotes (1)

[F1]Restricted stock unit award that vests as to 25% of the shares on December 31, 2017 and an additional 25% of the shares on each of September 30, 2018, 2019 and 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001618275

Filing Metadata

Form type: 4
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 8:28 AM ET
Size: 4.8 KB

View on SEC.gov